Sipuleucel-T (Provenge) injection the first immunotherapy agent (Vaccine) for hormone-refractory prostate cancer

Enock Anassi, Uche Anadu Ndefo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)197-202
Number of pages6
JournalP and T
Volume36
Issue number4
StatePublished - Apr 2011

ASJC Scopus Subject Areas

  • Pharmacology (medical)

Cite this